Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose glucagon for exercise-induced hypoglycemia in T1D
NCT05379686Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Sep 2022
- Primary completion
- May 2024
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of glucagon in hypoglycemia (2 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Percentage of Time in Target Glucose Range (PG: 3.9 - 10.0 mmol/l). Started Sep 2022; status: completed.
02
Drugs
glucagon
03
Conditions
hypoglycemia
Beyond the preview
Go deeper on NCT05379686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05379686.